NasdaqGS - Nasdaq Real Time Price USD

Neogen Corporation (NEOG)

12.14 +0.18 (+1.51%)
At close: April 26 at 4:00 PM EDT
12.10 -0.04 (-0.33%)
After hours: April 26 at 4:59 PM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
5/31/2023
5/31/2022
5/31/2021
5/31/2020
Total Revenue
929,238.00
822,447.00
527,159.00
468,459.00
418,170.00
Cost of Revenue
455,638.00
416,492.00
284,146.00
253,403.00
221,891.00
Gross Profit
473,600.00
405,955.00
243,013.00
215,056.00
196,279.00
Operating Expense
404,552.00
368,440.00
184,395.00
140,887.00
128,756.00
Operating Income
69,048.00
37,515.00
58,618.00
74,169.00
67,523.00
Net Non Operating Interest Income Expense
-66,459.00
-52,795.00
1,267.00
1,614.00
5,992.00
Other Income Expense
-2,845.00
-6,762.00
322.00
-515.00
-1,210.00
Pretax Income
-256.00
-22,042.00
60,207.00
75,268.00
72,305.00
Tax Provision
-1,822.00
828.00
11,900.00
14,386.00
12,830.00
Net Income Common Stockholders
1,566.00
-22,870.00
48,307.00
60,882.00
59,475.00
Diluted NI Available to Com Stockholders
1,566.00
-22,870.00
48,307.00
60,882.00
59,475.00
Basic EPS
0.02
-0.12
0.45
0.57
0.56
Diluted EPS
0.02
-0.12
0.45
0.57
0.56
Basic Average Shares
216,460.39
188,881.00
107,684.00
106,499.00
105,720.00
Diluted Average Shares
216,460.39
188,881.00
108,020.00
107,120.00
105,720.00
Total Operating Income as Reported
69,048.00
37,515.00
58,618.00
74,169.00
67,523.00
Total Expenses
860,190.00
784,932.00
468,541.00
394,290.00
350,647.00
Net Income from Continuing & Discontinued Operation
1,566.00
-22,870.00
48,307.00
60,882.00
59,475.00
Normalized Income
-645.00
-22,870.00
48,307.00
60,882.00
59,475.00
Interest Income
6,268.00
3,166.00
1,339.00
1,692.00
5,992.00
Interest Expense
72,727.00
55,961.00
72.00
78.00
--
Net Interest Income
-66,459.00
-52,795.00
1,267.00
1,614.00
5,992.00
EBIT
72,471.00
33,919.00
60,279.00
75,346.00
67,523.00
EBITDA
188,763.00
122,296.00
83,973.00
96,387.00
85,919.00
Reconciled Cost of Revenue
455,638.00
416,492.00
284,146.00
253,403.00
221,891.00
Reconciled Depreciation
116,292.00
88,377.00
23,694.00
21,041.00
18,396.00
Net Income from Continuing Operation Net Minority Interest
1,566.00
-22,870.00
48,307.00
60,882.00
59,475.00
Total Unusual Items Excluding Goodwill
3,685.00
--
--
--
--
Total Unusual Items
3,685.00
--
--
--
--
Normalized EBITDA
185,078.00
122,296.00
83,973.00
96,387.00
85,919.00
Tax Rate for Calcs
0.00
0.00
0.00
0.00
0.00
Tax Effect of Unusual Items
1,474.00
--
--
--
--
5/31/2020 - 8/23/1989

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

SHC Sotera Health Company
11.40
+0.71%
 
GH Guardant Health, Inc.
17.35
+1.11%
 
NEO NeoGenomics, Inc.
14.14
+2.09%
 
CRL Charles River Laboratories International, Inc.
229.03
+0.54%
 
XGN Exagen Inc.
1.4121
+0.86%
 
ICLR ICON Public Limited Company
308.31
+2.74%
 
MTD Mettler-Toledo International Inc.
1,238.09
+0.42%
 
OCX OncoCyte Corporation
2.4800
+1.64%
 
MYGN Myriad Genetics, Inc.
18.18
+1.11%
 
QGEN Qiagen N.V.
41.65
+1.39%